Company profile
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- Woburn, Massachusetts
- Founded
- 2016
- LinkedIn followers
- 4,206
- Office locations
- 1
Vertero Therapeutics, Inc. company summary
Vertero Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Woburn, Massachusetts, founded in 2016. On LinkedIn the company has around 12 employees and 4,206 followers. Its listed specialties include Neurological disorders and diseases, parkinson's disease, gut-brain axis, small molecule, Neurodegenerative diseases.
What technology does Vertero Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Vertero Therapeutics, Inc.
Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Vertero’s development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinson’s disease. The company's lead program, VT-5006, is designed to precisely treat a validated target in the gut that feeds the protein aggregation and inflammation implicated in Parkinson’s disease. Vertero is preparing to initiate a Phase 1 clinical trial of VT-5006. The company also has an asset targeting bile acid dysregulation in early development for undisclosed indications.
Specialties
Where is Vertero Therapeutics, Inc. located?
Vertero Therapeutics, Inc. lists 1 location.
Compare companies similar to Vertero Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Vertero Therapeutics, Inc. vertero.com | Biotechnology Research | 12 | 2016 | Woburn, Massachusetts |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Vertero Therapeutics, Inc.
What does Vertero Therapeutics, Inc. do?
Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Vertero’s development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinson’s disease. The company's lead program, VT-5006, is designed to precisely treat a validated target in the gut that feeds the protein aggregation and inflammation implicated in Parkinson’s disease. Vertero is preparing to initiate a Phase 1 clinical trial of VT-5006. The company also has an asset targeting bile acid dysregulation in early development for undisclosed indications.
How many employees does Vertero Therapeutics, Inc. have?
Vertero Therapeutics, Inc. has around 12 employees on LinkedIn.
Where is Vertero Therapeutics, Inc. headquartered?
Vertero Therapeutics, Inc. is headquartered in Woburn, Massachusetts.
When was Vertero Therapeutics, Inc. founded?
Vertero Therapeutics, Inc. was founded in 2016.
Build a lead list from companies like Vertero Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.